ES2117558B1 - Composicion oftalmica topica que comprende un derivado de 2-(4-(azolilbutil)-piperazinil-metil)-benzimidazol, principalmente para el tratamiento de la conjuntivitis alergica. - Google Patents

Composicion oftalmica topica que comprende un derivado de 2-(4-(azolilbutil)-piperazinil-metil)-benzimidazol, principalmente para el tratamiento de la conjuntivitis alergica.

Info

Publication number
ES2117558B1
ES2117558B1 ES09600606A ES9600606A ES2117558B1 ES 2117558 B1 ES2117558 B1 ES 2117558B1 ES 09600606 A ES09600606 A ES 09600606A ES 9600606 A ES9600606 A ES 9600606A ES 2117558 B1 ES2117558 B1 ES 2117558B1
Authority
ES
Spain
Prior art keywords
methyl
treatment
azolylbutyl
benzimidazole
piperazinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09600606A
Other languages
English (en)
Other versions
ES2117558A1 (es
Inventor
Altisent Maria Rosa Cuberes
Constansa Jordi Frigola
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Publication of ES2117558A1 publication Critical patent/ES2117558A1/es
Application granted granted Critical
Publication of ES2117558B1 publication Critical patent/ES2117558B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSICION OFTALMICA TOPICA QUE COMPRENDE UN DERIVADO DE 2-[4-(AZOLILBUTIL)-PIPERAZINIL-METIL]-BENZIMIDAZOL, PRINCIPALMENTE PARA EL TRATAMIENTO DE LA CONJUNTIVITIS ALERGICA. COMPRENDE POR LO MENOS UN COMPUESTO DE FORMULA GENERAL I. EN LA CUAL: N PUEDE TENER LOS VALORES 0 O 1, M PUEDE TENER LOS VALORES 2 O 3, Y HET REPRESENTA UN RADICAL HETEROAROMATICO DE FORMULA EN LA CUAL: X, Y, Z Y W, IGUALES O DIFERENTES, REPRESENTAN UN ATOMO DE NITROGENO O UN ATOMO DE CARBONO UNIDO A UN ATOMO DE HIDROGENO, UN ATOMO DE HALOGENO, UN RADICAL METILO, UN RADICAL CARBOXILATO DE ETILO, UN RADICAL CARBOXILICO O UN RADICAL SULFONICO, Y SUS SALES FISIOLOGICAMENTE ACEPTABLES, ASOCIADOS A UN VEHICULO OFTALMICAMENTE ACEPTABLE, EN PARTICULAR PARA EL TRATAMIENTO DE LA CONJUNTIVITIS ALERGICA.
ES09600606A 1995-03-14 1996-03-13 Composicion oftalmica topica que comprende un derivado de 2-(4-(azolilbutil)-piperazinil-metil)-benzimidazol, principalmente para el tratamiento de la conjuntivitis alergica. Expired - Fee Related ES2117558B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9502910A FR2731618B1 (fr) 1995-03-14 1995-03-14 Composition ophtalmique topique comprenant un derive de 2-(4-(azolylbutyl)-piperazinyl-methyl)-benzimidazole, notamment pour le traitement de la conjonctivite allergique

Publications (2)

Publication Number Publication Date
ES2117558A1 ES2117558A1 (es) 1998-08-01
ES2117558B1 true ES2117558B1 (es) 1999-09-16

Family

ID=9476989

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09600606A Expired - Fee Related ES2117558B1 (es) 1995-03-14 1996-03-13 Composicion oftalmica topica que comprende un derivado de 2-(4-(azolilbutil)-piperazinil-metil)-benzimidazol, principalmente para el tratamiento de la conjuntivitis alergica.

Country Status (9)

Country Link
US (1) US5641781A (es)
EP (1) EP0760663A1 (es)
JP (1) JPH10500427A (es)
AU (1) AU718008B2 (es)
CA (1) CA2190187A1 (es)
ES (1) ES2117558B1 (es)
FR (1) FR2731618B1 (es)
WO (1) WO1996028161A1 (es)
ZA (1) ZA962060B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
CN1700894A (zh) * 2002-10-18 2005-11-23 莫利化学医药公司 使用羊毛硫抗生素治疗干眼病的方法
EP1753445A4 (en) * 2004-05-06 2009-05-20 Molichem Medicines Inc TREATMENT OF EYE DISEASES AND EYE TREATMENTS WITH LANTIBIOTIC COMPOSITIONS
EP1750740A4 (en) * 2004-05-06 2009-06-10 Molichem Medicines Inc TREATMENT OF MEMBRANE-ASSOCIATED DISEASES AND DISORDERS USING COMPOSITIONS CONTAINING LANTIBIOTICS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665161B1 (fr) * 1990-07-26 1992-11-27 Esteve Labor Dr Nouveaux derives de benzimidazole, leur preparation et leur application en tant que medicaments.
FR2674856B1 (fr) * 1991-04-05 1993-07-30 Esteve Labor Dr Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments.
JP3527256B2 (ja) * 1992-12-09 2004-05-17 ロート製薬株式会社 抗アレルギー点眼剤

Also Published As

Publication number Publication date
CA2190187A1 (fr) 1996-09-19
JPH10500427A (ja) 1998-01-13
FR2731618B1 (fr) 1997-08-01
AU718008B2 (en) 2000-04-06
EP0760663A1 (fr) 1997-03-12
US5641781A (en) 1997-06-24
WO1996028161A1 (fr) 1996-09-19
ZA962060B (en) 1996-12-31
ES2117558A1 (es) 1998-08-01
FR2731618A1 (fr) 1996-09-20
AU5145296A (en) 1996-10-02

Similar Documents

Publication Publication Date Title
WO2004002986A3 (en) Novel benzimidazole derivatives
DK0449216T3 (da) 3,5-Di-tertiærbutyl-4-hydroxyphenylmethylenderivater af 2-substituerede thiazolidinoner, oxazolidinoner og imidazolidinoner som antiinflammatoriske midler
ATE464299T1 (de) Neues phenylalaninderivat
ES2174465T3 (es) Compuestos triazol y su utilizacion como ligandos de dopamina-d.
CR6540A (es) Trifluorobutenos nematicidas
ES2179822T3 (es) Nuevas 4-arilpiperazinas y 4-arilpiperidinas.
AR038431A2 (es) Derivados 2-desoxo-15-alquilo de marcfortina
DE69413274D1 (de) Chinoloncarbonsäurederivate, ihre Herstellung und ihre Verwendung als Zelladhäsion Inhibitoren
ATE179173T1 (de) 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy 1,3-propandiol-derivate
DE69708968D1 (de) Arylacrylamidderivate als 5HT1 Agoniste oder Antagoniste
IT1295933B1 (it) 2-(2'-idrossifenil)benzotriazoli e procedimento per la loro preparazione
DK0842165T3 (da) Thiazolidin-4-carboxylsyrederivater som cytobeskyttende midler
ES2117558B1 (es) Composicion oftalmica topica que comprende un derivado de 2-(4-(azolilbutil)-piperazinil-metil)-benzimidazol, principalmente para el tratamiento de la conjuntivitis alergica.
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
ES2093091T3 (es) Derivado de glutation.
ES2075272T5 (es) Composiciones dermatologicas conteniendo acido cis-urocanico.
AR009105A1 (es) Derivados de n-(benzotiazol-2-il) piperidina-1-etanamina, su preparacion y aplicacion en terapeutica
ES2104509B1 (es) Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
ATE147628T1 (de) Iloprost mit wirkung gegen cerebrale malaria
NO305170B1 (no) Morfolinderivat
DE60310609D1 (de) Verfahren zur herstellung von 2-aminomethylpyridin-derivaten
GT199500039CA (es) Compuestos ariltios
MX9205385A (es) Perhidro-1-h-pirido(1,2-a)piracinas 2-sustituidas neurolepticas.
ATE182594T1 (de) Thiazolotriazol- und thiazolodiazolderivate mit fungizider aktivität
ATE226192T1 (de) Penizillaminamid-derivate

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19980801

Kind code of ref document: A1

Effective date: 19980801

FD1A Patent lapsed

Effective date: 20040503